Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

recurrent Gastrointestinal Stromal Tumors

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Metastatic or Recurrent GISTs

Broader topic: Gastrointestinal Stromal Tumors

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Treatment of Metastatic or Recurrent GISTs

    Study evidence for this setting

    4 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT00028002 · Source cited / selected · Scope: unclear

    Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

    4 outcome links · 1 safety-group records · 1 quality-of-life measures

    →

    NCT00112463 · Registry condition search · Scope: unclear

    Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

    4 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01154452 · Registry condition search · Scope: unclear

    Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

    3 outcome links · 4 safety-group records · 0 quality-of-life measures

    →

    NCT02508532 · Source cited / selected · Scope: unclear

    (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

    6 outcome links · 7 safety-group records · 0 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice